Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTUITIVE SURGICAL INCISRG · Entity 2878 | Director | April 23, 2010 | April 23, 2010 |
| MiniMed Group, Inc.MMED · Entity 3758 | Director | October 09, 2026 | October 13, 2026 |
| Outset Medical, Inc.OM · Entity 7026 | Director | June 04, 2026 | June 05, 2026 |
| ViewRay, Inc.VRAY · Entity 111118 | Director | January 04, 2021 | January 05, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTUITIVE SURGICAL INC
Report date April 23, 2010 · Filed April 23, 2010
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2010-04-23 transaction · row 19
19 source rows · reconciled sequenceRow 1 · 2010-04-23 · Exercise / conversion · Acquired 4,250 · Balance 4,250 Row 2 · 2010-04-23 · Sale · Disposed 200 · Balance 4,050 Row 3 · 2010-04-23 · Sale · Disposed 300 · Balance 3,750 Row 4 · 2010-04-23 · Sale · Disposed 100 · Balance 3,650 Row 5 · 2010-04-23 · Sale · Disposed 400 · Balance 3,250 Row 6 · 2010-04-23 · Sale · Disposed 200 · Balance 3,050 Row 7 · 2010-04-23 · Sale · Disposed 100 · Balance 2,950 Row 8 · 2010-04-23 · Sale · Disposed 200 · Balance 2,750 Row 9 · 2010-04-23 · Sale · Disposed 100 · Balance 2,650 Row 10 · 2010-04-23 · Sale · Disposed 100 · Balance 2,550 Row 11 · 2010-04-23 · Sale · Disposed 300 · Balance 2,250 Row 12 · 2010-04-23 · Sale · Disposed 100 · Balance 2,150 Row 13 · 2010-04-23 · Sale · Disposed 300 · Balance 1,850 Row 14 · 2010-04-23 · Sale · Disposed 100 · Balance 1,750 Row 15 · 2010-04-23 · Sale · Disposed 200 · Balance 1,550 Row 16 · 2010-04-23 · Sale · Disposed 6 · Balance 1,544 Row 17 · 2010-04-23 · Sale · Disposed 104 · Balance 1,440 Row 18 · 2010-04-23 · Sale · Disposed 90 · Balance 1,350 Row 19 · 2010-04-23 · Sale · Disposed 1,350 · Balance 0 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $135.39 · Expires 2019-04-23 | Direct | 0 |
Reported balance
After 2010-04-23 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2010-04-23 · Exercise / conversion · Disposed 4,250 · Balance 0 F1: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant date.
MiniMed Group, Inc.
Report date October 09, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,684 |
Reported balance
After 2026-10-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-09 · Grant · Acquired 11,795 · Balance 25,684 F1: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date. F2: Includes shares of common stock to be issued in connection with the vesting of one or more RSUS. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date.
F2: Includes shares of common stock to be issued in connection with the vesting of one or more RSUS.
Outset Medical, Inc.
Report date June 04, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,585 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 10,667 · Balance 24,585 F1: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders |
| Common StockSEC Table I · non-derivative | IndirectGrossman Fam Trust | 12,845 |
Reported balance
Holding disclosure · report date 2026-06-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 12,845 |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders
ViewRay, Inc.
Report date January 04, 2021 · Filed January 05, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy The D. Keith and Hallie H. Grossman Family Living Trust | 100,855 |
Reported balance
After 2021-01-04 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2021-01-04 · Grant · Acquired 7,800 · Balance 100,855 F1: The reported securities are DSUs that entitle the Reporting Person to receive one share of Common Stock per DSU upon the earliest of (i) the Reporting Person's termination of service from the Issuer's board of directors, (ii) a Change of Control of the Issuer as defined in the Issuer's Amended & Restated 2015 Equity Incentive Award Plan or (iii) January 4, 2031 (the tenth anniversary of the grant date). 1/12th of these DSUs shall vest on the last day of each calendar month beginning on January 31, 2021 such that 100% of the DSUs will be vested on December 31, 2021, subject to the Reporting Person remaining a service provider through each such vesting date. F2: These DSUs were issued to the reporting person pursuant to ViewRay Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $50,000. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are DSUs that entitle the Reporting Person to receive one share of Common Stock per DSU upon the earliest of (i) the Reporting Person's termination of service from the Issuer's board of directors, (ii) a Change of Control of the Issuer as defined in the Issuer's Amended & Restated 2015 Equity Incentive Award Plan or (iii) January 4, 2031 (the tenth anniversary of the grant date). 1/12th of these DSUs shall vest on the last day of each calendar month beginning on January 31, 2021 such that 100% of the DSUs will be vested on December 31, 2021, subject to the Reporting Person remaining a service provider through each such vesting date.
F2: These DSUs were issued to the reporting person pursuant to ViewRay Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $50,000.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NEVRO CORP
Report date April 03, 2025 · Filed April 03, 2025
Section 16 reporting ended · disclosed 2025-04-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-04-03 transaction · row 1
1 source rowRow 1 · 2025-04-03 · Disposition to issuer · Disposed 228,552 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. ("Globus") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus ("Merger Sub"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the "Effective Time"). F2: At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the "Merger Consideration"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. ("Globus") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus ("Merger Sub"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the "Effective Time").
F2: At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the "Merger Consideration"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration.
Zeltiq Aesthetics Inc
Report date April 28, 2017 · Filed April 28, 2017
Section 16 reporting ended · disclosed 2017-04-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-04-28 transaction · row 1
1 source rowRow 1 · 2017-04-28 · Other · Disposed 14,137 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc., a wholly owned subsidiary of Allergan plc ("Allergan"), Blizzard Merger Sub, Inc. ("Merger Sub"), and the Issuer (the "Merger Agreement"), as approved by the board of directors of the Issuer, whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the "Merger"). F2: Pursuant to the terms of the Merger Agreement, out of the total of 14,137 shares held by the Reporting Person, (i) 11,669 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes (the "Merger Consideration"), and (ii) 2,468 shares, representing unvested restricted stock units, were converted into a corresponding award of restricted stock units with respect to ordinary shares of Allergan, on the same terms and conditions as were applicable under such restricted stock units, as adjusted based on an exchange ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.49 · Expires 2023-10-23 | Direct | 0 |
Reported balance
After 2017-04-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-04-28 · Other · Disposed 18,987 · Balance 0 F3: This vested option was canceled and converted in the Merger into the right to receive cash equal to the number of shares subject to such option multiplied by the excess, if any, of the Merger Consideration over the exercise price of such option. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.48 · Expires 2024-05-29 | Direct | 0 |
Reported balance
After 2017-04-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-04-28 · Other · Disposed 30,000 · Balance 0 F3: This vested option was canceled and converted in the Merger into the right to receive cash equal to the number of shares subject to such option multiplied by the excess, if any, of the Merger Consideration over the exercise price of such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc., a wholly owned subsidiary of Allergan plc ("Allergan"), Blizzard Merger Sub, Inc. ("Merger Sub"), and the Issuer (the "Merger Agreement"), as approved by the board of directors of the Issuer, whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the "Merger").
F2: Pursuant to the terms of the Merger Agreement, out of the total of 14,137 shares held by the Reporting Person, (i) 11,669 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes (the "Merger Consideration"), and (ii) 2,468 shares, representing unvested restricted stock units, were converted into a corresponding award of restricted stock units with respect to ordinary shares of Allergan, on the same terms and conditions as were applicable under such restricted stock units, as adjusted based on an exchange ratio.
F3: This vested option was canceled and converted in the Merger into the right to receive cash equal to the number of shares subject to such option multiplied by the excess, if any, of the Merger Consideration over the exercise price of such option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2020 Filed Sep 18, 2020 00:20 UTC | Outset Medical, Inc. OM · Entity 7026 | ConversionCommon Stock | 10,257 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-20-020791 · form4.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by The D. Keith and Hallie H. Grossman Family Living Trust Disclosed balance after: 11,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date. F3 · price: The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date. F1 · ownership.direct: These shares of common stock of the Issuer ("Shares") are held directly by The D. Keith and Hallie H. Grossman Family Living Trust, for which the reporting person and his spouse serve as trustees. F1 · ownership.nature: These shares of common stock of the Issuer ("Shares") are held directly by The D. Keith and Hallie H. Grossman Family Living Trust, for which the reporting person and his spouse serve as trustees. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 16:12 UTC | NEVRO CORP NVRO · Entity 12422 | Tax withholdingCommon Stock | 4,998 | $127.64 | $637,944.72 |
DisclosureSEC source: 0001567619-20-012505 · doc1.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,891 F1 · balance_after: Includes 97,207 restricted stock units. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 22:07 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 52,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037382 · doc4.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The D. Keith and Hallie H. Grossman Family Living Trust Disclosed balance after: 93,055 F1 · shares: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on June 15, 2021, subject to the Reporting Person remaining a service provider through such date. Read SEC document |
| April 12, 2020 Filed Apr 14, 2020 16:26 UTC | NEVRO CORP NVRO · Entity 12422 | GrantCommon Stock | 32,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-007937 · doc1.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,889 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually on April 12 of each year, beginning April 12, 2021, subject to the Reporting Person's continued service to the issuer. F2 · balance_after: Includes 106,466 RSUs. Read SEC document |
| March 19, 2020 Filed Mar 20, 2020 17:07 UTC | NEVRO CORP NVRO · Entity 12422 | Tax withholdingCommon Stock | 4,994 | $80.30 | $401,018.20 |
DisclosureSEC source: 0001567619-20-006850 · doc1.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,497 F1 · balance_after: Includes 74,074 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 23:09 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 12,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-002090 · doc4.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The D. Keith and Hallie H. Grossman Family Living Trust Disclosed balance after: 40,303 F1 · shares: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on June 12, 2020, subject to the Reporting Person remaining a service provider through such date. Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 19:16 UTC | NEVRO CORP NVRO · Entity 12422 | Tax withholdingCommon Stock | 4,507 | $111.50 | $502,530.50 |
DisclosureSEC source: 0001567619-19-023490 · doc1.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,491 F1 · balance_after: Includes 83,334 restricted stock units. Read SEC document |
| September 19, 2019 Filed Sep 20, 2019 18:44 UTC | NEVRO CORP NVRO · Entity 12422 | Tax withholdingCommon Stock | 3,912 | $89.31 | $349,380.72 |
DisclosureSEC source: 0001567619-19-018619 · doc1.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,998 F1 · balance_after: Includes 92,593 restricted stock units. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 16:47 UTC | NEVRO CORP NVRO · Entity 12422 | Tax withholdingCommon Stock | 3,201 | $64.40 | $206,144.40 |
DisclosureSEC source: 0001567619-19-013836 · doc1.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,910 F1 · balance_after: Includes 101,852 restricted stock units. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:40 UTC | NEVRO CORP NVRO · Entity 12422 | GrantCommon Stock | 111,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-007430 · doc1.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,111 F1 · balance_after: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs vest in substantially equal quarterly installments over three years, subject to the Reporting Person's continued service to the issuer. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 01:16 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 18,668 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-19-000198 · ownership.xml · nonDerivative · entry 2 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The D. Keith and Hallie H. Grossman Family Living Trust Disclosed balance after: 27,596 F3 · shares: The reported securities are RSUs that entitle the holder to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on January 2, 2020 (the one-year anniversary of the grant date), subject to the Reporting Person remaining a service provider through such date. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 01:16 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 8,928 | $6.16 | $54,996.48 |
DisclosureSEC source: 0000950103-19-000198 · ownership.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The D. Keith and Hallie H. Grossman Family Living Trust Disclosed balance after: 8,928 F1 · shares: The reported securities are DSUs that entitle the holder to receive one share of Common Stock per DSU upon the earliest of (i) the Reporting Person's termination of service from the Issuer's board of directors, (ii) a Change of Control of the Issuer as defined in the Issuer's 2015 Equity Incentive Award Plan or (iii) January 2, 2029 (the tenth anniversary of the grant date). 1/12th of these DSUs shall vest on the last day of each calendar month beginning on January 31, 2019 such that 100% of the DSUs will be vested on December 31, 2019, subject to the Reporting Person remaining a service provider through each such vesting date. F2 · price: These DSUs were issued to the D. Keith and Hallie H. Grossman Family Living Trust in respect of the Reporting Person's services to the Issuer pursuant to ViewRay Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $55,000. Read SEC document |
| December 21, 2018 Filed Dec 27, 2018 02:45 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantStock Option (right to buy) · Derivative | 15,685 | $0.00 Strike: $5.21 | $0.00 |
DisclosureSEC source: 0000950103-18-015063 · dp100062_4-grossman.xml · derivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The D. Keith and Hallie H. Grossman Family Living Trust Disclosed balance after: 15,685 Underlying: Common Stock · 15,685 shares Expires 2028-12-21 F1 · derivative.exercise_date: All of the shares subject to the option had vested and were exercisable as of December 2018. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 22:58 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantStock Option (right to buy) · Derivative | 38,080 | $0.00 Strike: $11.92 | $0.00 |
DisclosureSEC source: 0000950103-18-009427 · ownership.xml · derivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The D. Keith and Hallie H. Grossman Family Living Trust Disclosed balance after: 38,080 Underlying: Common Stock · 38,080 shares Expires 2028-08-01 F1 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest and become exercisable on each monthly anniversary measured from August 1, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person remaining a service provider through each such vesting date. Read SEC document |
| April 28, 2017 Filed Apr 28, 2017 13:36 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | OtherStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $17.48 | $0.00 |
DisclosureSEC source: 0001209191-17-028608 · doc4.xml · derivative · entry 3 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2024-05-29 F3 · derivative.exercise_date: This vested option was canceled and converted in the Merger into the right to receive cash equal to the number of shares subject to such option multiplied by the excess, if any, of the Merger Consideration over the exercise price of such option. Read SEC document |
| April 28, 2017 Filed Apr 28, 2017 13:36 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | OtherStock Option (Right to Buy) · Derivative | 18,987 | $0.00 Strike: $9.49 | $0.00 |
DisclosureSEC source: 0001209191-17-028608 · doc4.xml · derivative · entry 2 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,987 shares Expires 2023-10-23 F3 · derivative.exercise_date: This vested option was canceled and converted in the Merger into the right to receive cash equal to the number of shares subject to such option multiplied by the excess, if any, of the Merger Consideration over the exercise price of such option. Read SEC document |
| April 28, 2017 Filed Apr 28, 2017 13:36 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | OtherCommon Stock | 14,137 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-028608 · doc4.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc., a wholly owned subsidiary of Allergan plc ("Allergan"), Blizzard Merger Sub, Inc. ("Merger Sub"), and the Issuer (the "Merger Agreement"), as approved by the board of directors of the Issuer, whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the "Merger"). F2 · kind: Pursuant to the terms of the Merger Agreement, out of the total of 14,137 shares held by the Reporting Person, (i) 11,669 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes (the "Merger Consideration"), and (ii) 2,468 shares, representing unvested restricted stock units, were converted into a corresponding award of restricted stock units with respect to ordinary shares of Allergan, on the same terms and conditions as were applicable under such restricted stock units, as adjusted based on an exchange ratio. F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc., a wholly owned subsidiary of Allergan plc ("Allergan"), Blizzard Merger Sub, Inc. ("Merger Sub"), and the Issuer (the "Merger Agreement"), as approved by the board of directors of the Issuer, whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the "Merger"). F2 · price: Pursuant to the terms of the Merger Agreement, out of the total of 14,137 shares held by the Reporting Person, (i) 11,669 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes (the "Merger Consideration"), and (ii) 2,468 shares, representing unvested restricted stock units, were converted into a corresponding award of restricted stock units with respect to ordinary shares of Allergan, on the same terms and conditions as were applicable under such restricted stock units, as adjusted based on an exchange ratio. Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,250 | $0.00 Strike: $135.39 | $0.00 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · derivative · entry 20 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,250 shares Expires 2019-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant date. Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 1,350 | $367.06 | $495,531.00 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 19 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 90 | $367.09 | $33,038.10 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 18 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,350 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 104 | $367.10 | $38,178.40 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 17 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,440 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 6 | $367.11 | $2,202.66 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 16 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,544 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 200 | $367.22 | $73,444.00 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 15 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,550 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 100 | $367.28 | $36,728.00 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 14 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 300 | $367.29 | $110,187.00 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 13 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,850 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 100 | $367.30 | $36,729.50 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 12 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 300 | $367.30 | $110,190.00 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 11 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 100 | $367.30 | $36,730.21 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 10 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,550 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 100 | $367.30 | $36,730.26 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 9 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,650 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 200 | $367.30 | $73,460.56 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 8 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 100 | $367.30 | $36,730.32 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 7 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,950 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 200 | $367.31 | $73,462.00 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 6 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 400 | $367.32 | $146,928.00 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 5 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,250 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 100 | $367.34 | $36,734.00 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 4 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,650 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 300 | $367.36 | $110,208.00 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 3 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 200 | $367.38 | $73,476.00 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 2 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,050 Read SEC document |
| April 23, 2010 Filed Apr 23, 2010 23:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 4,250 | $135.39 | $575,407.50 |
DisclosureSEC source: 0001252986-10-000028 · edgardoc.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2010 Filed Feb 20, 2010 00:15 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $288.50 | $0.00 |
DisclosureSEC source: 0001252986-10-000013 · edgardoc.xml · derivative · entry 3 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant date. Read SEC document |
| February 19, 2010 Filed Feb 20, 2010 00:15 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 5,000 | $342.18 | $1,710,900.00 |
DisclosureSEC source: 0001252986-10-000013 · edgardoc.xml · nonDerivative · entry 2 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 19, 2010 Filed Feb 20, 2010 00:15 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 5,000 | $288.50 | $1,442,500.00 |
DisclosureSEC source: 0001252986-10-000013 · edgardoc.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 17:09 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $133.31 | $0.00 |
DisclosureSEC source: 0001252986-09-000041 · edgardoc.xml · derivative · entry 11 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2017-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant date. Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 17:09 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 598 | $292.00 | $174,616.00 |
DisclosureSEC source: 0001252986-09-000041 · edgardoc.xml · nonDerivative · entry 10 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 17:09 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 302 | $292.02 | $88,190.04 |
DisclosureSEC source: 0001252986-09-000041 · edgardoc.xml · nonDerivative · entry 9 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 17:09 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 100 | $292.08 | $29,208.00 |
DisclosureSEC source: 0001252986-09-000041 · edgardoc.xml · nonDerivative · entry 8 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 17:09 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 200 | $292.04 | $58,408.00 |
DisclosureSEC source: 0001252986-09-000041 · edgardoc.xml · nonDerivative · entry 7 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 17:09 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 200 | $292.05 | $58,410.00 |
DisclosureSEC source: 0001252986-09-000041 · edgardoc.xml · nonDerivative · entry 6 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 17:09 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 100 | $292.06 | $29,206.00 |
DisclosureSEC source: 0001252986-09-000041 · edgardoc.xml · nonDerivative · entry 5 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 17:09 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 100 | $292.07 | $29,207.00 |
DisclosureSEC source: 0001252986-09-000041 · edgardoc.xml · nonDerivative · entry 4 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 17:09 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 200 | $292.29 | $58,458.00 |
DisclosureSEC source: 0001252986-09-000041 · edgardoc.xml · nonDerivative · entry 3 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 17:09 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 700 | $292.33 | $204,631.00 |
DisclosureSEC source: 0001252986-09-000041 · edgardoc.xml · nonDerivative · entry 2 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.